Andreas Trumpp

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression

  Nature Communications · 2026-06-16

• Nociceptor neurons suppress antitumor immunity in breast cancerPreprint

  Research Square · 2026-06-09

• A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells

  Nature Cell Biology · 2026-05-25

• Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype

  Blood · 2026-05-21

• Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML

  Cell stem cell · 2026-05-07

• Abstract CT186: Pulmonary toxicity associated with increased 6-OH-paclitaxel exposure in pancreatic cancer patients treated with nab-paclitaxel, gemcitabine and cobicistat: Results of the IntenSify trial

  Cancer Research · 2026-04-17

• Abstract SY04-02: Neuronal innervation of pancreatic cancer

  Cancer Research · 2026-04-17

• Abstract 1306: Developing a real-world clinical genomic platform to deliver precision oncology in underrepresented populations.

  Cancer Research · 2026-04-03

• Abstract 1803: Dynamic copy number changes and <i>de novo</i> generation of extrachromosomal DNA modulate therapy resistance.

  Cancer Research · 2026-04-03

• Abstract 1582: Integrative functional and multi-omics profiling reveals divergent natural killer cell responses and tumor cell plasticity in breast and ovarian cancer

  Cancer Research · 2026-04-03

• Cancer neuroscience: The past, the present, and the road ahead

  Cell · 2026-04-01 · 2 citations

• Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma

  Nature Cancer · 2026-03-25 · 1 citations

• Supplementary Figure 2 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

  2026-02-19

• Supplementary Figure 1 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

  2026-02-19

• Supplementary Figure 3 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

  2026-02-19

• Supplementary Table 2 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

  2026-02-19

• Supplementary Table 1 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

  2026-02-19

• Supplementary Figure 5 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

  2026-02-19

• Supplementary Figure 4 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

  2026-02-19

• Supplementary Figure 5 from Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation

  2026-02-16